510(k) K223873
K223873 is an FDA 510(k) premarket notification submitted by Pyrames, Inc. for the device "Boppli Infant Blood Pressure Monitor". The FDA issued a decision of Substantially Equivalent on Sep 29, 2023. The device falls under product code DXN (System, Measurement, Blood-Pressure, Non-Invasive), a Class II device regulated under 21 CFR 870.1130.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 29, 2023
- Date Received
- Dec 23, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Measurement, Blood-Pressure, Non-Invasive
- Device Class
- Class II
- Regulation Number
- 870.1130
- Review Panel
- CV
- Submission Type
- 510(k)